Page under construction. Our active substance depth analysis for tesamoreline is in editing. As long as you see the quick facts in the sidebar and the standard sections below.
What is tesamoreline
GHRH analogue approved as Egrifta for HIV-associated lipodystrophy.
Mechanism of action
Full mechanism breakdown in preparation. Emphasis: receptor binding, downstream effects and relevant pathway diagrams.
Applications
- Category HGH system
- Application: subcutaneous
- Typical dosage: 1000-2000 mcg
Study situation
Study section in preparation. We link here to PubMed sources with comment.
Mixing and dosage
Half-life 0.5 h, frequency 1x daily. Use it. Reconstitution calculator for concrete units on the insulin syringe.
Legal status
Most peptides in U.S. are available as a research substance (RUO). Pharmaceutical versions such as Ozempic (semaglutidee) or Mounjaro (tirzepatide) are subject to prescription.